Objective: Correct subtyping of primary aldosteronism (PA) is essential for good surgical outcomes. Adrenal vein sampling (AVS) and/or computed tomography (CT) are used for PA subclassification. Clinical and/or biochemical improvement after surgery, however, is not always achieved in patients with presumed unilateral PA. We aimed to identify the pitfalls in PA subclassification leading to surgical treatment failures. Results: Of 55 patients who underwent adrenalectomy, three (5.5%) had no improvement of PA. All three patients underwent partial adrenalectomy to remove a CTdetected nodule present on the same side with AVS lateralization. Immunohistochemistry revealed a CYP11B2-negative nodule in both cases available. All patients who underwent total adrenalectomy based on AVS lateralization benefitted from surgery, including three patients with unilateral unsuccessful AVS and aldosterone suppression in the catheterized side vs inferior vena cava.
| INTRODUCTION
Primary aldosteronism (PA) is the most common identifiable form of secondary hypertension.
1 PA is highly prevalent among patients with resistant hypertension and is diagnosed in over 10% of the patients referred to specialized centres. [2] [3] [4] PA is associated with increased cardiovascular morbidity and mortality as compared to equivalent degrees of essential hypertension, [5] [6] [7] and hence, early recognition and treatment of PA is imperative. 8 PA is traditionally subclassified as either bilateral hyperaldosteronism (BHA) or aldosterone producing Richard J. Auchus and Adina F. Turcu contributed equally to this work.
adenomas (APA), 1 although some patients have features of both subtypes. Correct subclassification of PA is essential, as patients with unilateral PA can benefit from surgical treatment. Immunostaining for aldosterone synthase (CYP11B2), the key enzyme in aldosterone production, is not widely available; consequently, when postoperative clinical assessment demonstrates surgical cure of hyperaldosteronism, it is assumed that a histologically identified macroscopic adrenal tumour was the primary source of aldosterone. Since the development of highly specific CYP11B2 antibodies, it has been demonstrated that the subclassification of PA spans a continuum, ranging from single or multiple APA, to small aldosterone producing cell clusters (APCC), to zona glomerulosa hyperplasia. [9] [10] [11] [12] The variable immunohistochemistry findings in resected adrenals from patients with PA underscore the limitations of adrenal imaging in identifying the source(s) of aldosterone excess.
Adrenal vein sampling (AVS) is considered the most accurate method for determining whether one or both adrenals produce excess aldosterone. 8 Aside from patients younger than 35 years with unequivocal PA, 13, 14 cross-sectional adrenal imaging findings are frequently discordant with the aldosterone source as lateralized by AVS. [15] [16] [17] [18] [19] Nevertheless, resolution of PA after unilateral adrenalectomy is not always achieved, even if the decision is based on AVS lateralization, 9, 13, 20 in part because AVS technique and interpretation vary widely between centres. 21 Moreover, AVS results might be influenced by several antihypertensive agents and by autonomous adrenal cortisol synthesis. 1, 8 For these reasons, the supremacy of AVS in PA subclassification has been questioned.
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Several studies have focused on outcomes after adrenalectomy in PA, but the emphasis has been on success rates rather than on causes of treatment failure. While clinical improvement is achieved in the majority of PA cases treated surgically, 9,13,22-24 data regarding contributors to surgical treatment failure have been scarce. In the present study, we aimed to identify the pitfalls in PA subclassification, leading to the absence of PA improvement after surgical treatment.
| PATIENTS AND METHODS

| Study participants
In our centre, all patients with PA considered for surgical treatment undergo AVS. We studied patients who underwent AVS at the (aldosterone/cortisol) IVC were used to assess lateralization. Unilateral PA was diagnosed if the LI was ≥2 before and ≥4 after cosyntropin administration, respectively. A CI <1 defined contralateral suppression.
| Clinical assessment
| Immunohistochemistry
We assessed the aldosterone synthetic capacity of the surgically 
| Statistical analysis
Statistical differences in measured parameters between groups were evaluated using the Mann-Whitney U-test. A P value < .05 was considered significant.
| RESULTS
| Demographic and diagnostic data
Between Because catheterization is less often successful without cosyntropin administration, AVS data after cosytropin administration have been preferentially used for clinical decisions in our centre, and PA will be further referred to as unilateral or bilateral based on these results, unless otherwise specified. In unilateral PA, median PAC (330 ng/L vs 220 ng/L, P < .001) and ARR (1970 vs 870, P < .001) were higher, and PRA was lower (0.1 μg/L/h vs 0.3 μg/ L/h, P = .007) than in bilateral PA (Table 1) . Hypokalaemia was more frequent in patients with unilateral PA (97%) than in those with bilateral PA (75%).
Adrenal CT was performed in 158 patients (Figure 2 co-secretion from the ipsilateral side; two had bilateral PA, and in one patient AVS was unsuccessful.
| Postsurgical outcomes
In total, 55 (32%) patients underwent unilateral adrenalectomy, Adrenalectomy was performed in four patients in whom AVS had failed on one side, three with an aldosterone/cortisol ratio lower in the successfully catheterized side than in IVC. All four patients experienced resolution of PA and a decline in the ATC/DDD index.
| Immunohistochemistry
To understand the pathophysiology of poor clinical outcomes after adrenalectomy, as well as successful outcomes in cases with incomplete AVS data, we performed immunohistochemical staining for CYP11B2 on the adrenal glands from patients who failed surgical treatment (two patients; for the third, pathology specimen was not available) and patients in whom AVS failed unilaterally (four patients).
In the two patients with available pathology specimens who had failed surgical treatment, the cortical adenomas removed were negative for CYP11B2, while the entire tissue was diffusely positive for CYP17A1 ( Figure 3 , A and B, Cases 2 and 3 in Table 2 ). These results demonstrated that despite AVS lateralization, the largest nodule was not the cause of PA in these patients. One of these patients under- Of the four patients with unilateral AVS failure who underwent unilateral adrenalectomy, CYP11B2 staining localized to the macroscopic nodule in three. In the fourth patient, however, the CT-detected nodule was negative for CYP11B2 and positive for CYP17A1, while another, smaller, nodular structure showed positive CYP11B2 and weak CYP17A1 expression, suggesting that the source of excess aldosterone production was the smaller nodule rather than the one identified on CT ( Figure 3C ).
| DISCUSSION
Adrenal vein sampling has been widely accepted as the "gold standard" for lateralization of PA. 8, 16, 27 The basis for recommending AVS in all patients with PA older than 35 who might consider surgery 8 has emerged from numerous studies demonstrating poor correlation of AVS with cross-sectional imaging. 13, 14, 16 Previous studies have largely focused on success rates after adrenalectomy, but the cases with absent clinical benefit after surgery have been poorly studied.
Published data suggest that both CT and AVS are imperfect tools for PA subclassification. 13, 20 In the present study, we sought to identify can be contralateral to the side suggested by AVS as the source of autonomous aldosterone production. 13, 16 Taken together, these results suggest that while macroscopic APAs are more common than other types of unilateral PA, surgical planning cannot be reliably based on CT findings.
Next, we investigated potential sources of error in AVS interpretation. AVS technique and criteria for successful catheterization and lateralization vary widely among centres. 21, 30, 31 In our institution, samples are routinely obtained both before and after cosyntropin stimulation. The rate of successful catheterization in our institution using the stated SI criteria is considerably higher when cosyntropin is used (94% vs 72%), even in the hands of experienced interventional radiologists, in agreement with the experiences reported by other centres. 32, 33 The proportion of uni-vs bilateral PA was comparable before and after cosyntropin administration, although 10% of AVS studies yielded discrepant results. In total, 6/16 patients with discordant prevs postcosyntropin AVS lateralization had adrenalectomy: one who lateralized only before and five who lateralized only after cosyntropin.
Of these, only one patient-whose surgery was a partial adrenalectomy-did not have improvement of PA after surgery. In a recent study of 175 patients who underwent AVS at another tertiary referral centre, the lateralization index was discordant in 28% of cases, the majority of which lateralized only prior to cosyntropin administration. Table 2 ). Both nodules demonstrated no CYP11B2 expression, while CYP17A1 was positive in the nodules. (C) Adrenal tissue resected from a patient who had unilaterally unsuccessful AVS. The CT-detected nodule was negative for CYP11B2, while another smaller nodule had CYP11B2 expression. [Colour figure can be viewed at wileyonlinelibrary.com]
and contralateral suppression. [34] [35] [36] As was previously observed, 37 we found that contralateral suppression was more frequent post-as compared to precosyntropin administration. These results, along with the favourable surgical outcomes in such patients, [35] [36] [37] Furthermore, MRA use was permitted postoperatively, allowing blood pressure control in uncured patients from both groups.
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Similar to previous reports, the concordance between AVS and CT findings in our study was only 53% and highest in cases with single adrenal nodules. Moreover, unilateral PA was diagnosed by AVS in 35%
of patients with no detectable adrenal abnormalities by CT, and all of these patients benefited clinically from adrenalectomy. These results reinforce that, in contrast to cases of hypercortisolism, autonomous aldosterone synthesis from a small group of highly efficient cells might be sufficient to cause disease. Multiple adrenocortical micronodules or diffuse hyperplasia of the zona glomerulosa has been described in such patients. 12 Taken together, these results suggest that over a third of patients with PA could be denied the opportunity of surgical treatment if subtyping was based on cross-imaging studies.
In summary, we explored the reasons behind surgical failure and the pitfalls of the commonly used PA subclassification tools, CT and AVS. Among the strengths of our study are the large numbers of patients captured within a tertiary referral adrenal centre and the routine collection of serum both before and after cosyntropin administration during AVS. Most importantly, implementing CYP11B2 immunostaining, we demonstrated that autonomous aldosterone synthesis does not always correspond with radiological findings, even when ipsilateral AVS lateralization is present. Consequently, our data caution against reliance on cross-sectional imaging as a criterion for PA lateralization or guide for adrenalectomy. The limitations to our data include the retrospective design and the number of patients who did not undergo surgery. In addition, postsurgical evaluation was heterogeneous and relatively limited, making it unfeasible to assess a range of outcomes.
Carefully planned prospective studies, incorporating uniform criteria for postoperative follow-up, remain necessary to clarify the optimal approach to PA lateralization in cases amenable to surgical treatment.
